Evidence map

TrialBreast cancer research and treatment2024

Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane.

Bjørn-Erik Bertelsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38649619